Please login to the form below

Not currently logged in

Poseida Therapeutics

This page shows the latest Poseida Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Takeda agrees on $2bn deal with Code Bio to expand its gene therapy programmes

In October 2021, Takeda signed a $3.6bn deal with Poseida Therapeutics on gene therapies for six to eight programmes.

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...